| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Panbela Therapeutics, Inc. | V.P. of Finance & CFO | Stock Option (right to buy) | 25,480 | 01 Oct 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| PBLA | Panbela Therapeutics, Inc. | 01 Oct 2024 | 1 | $0 | 4 | V.P. of Finance & CFO | 03 Oct 2024, 16:26 |
| PBLA | Panbela Therapeutics, Inc. | 27 Mar 2023 | 1 | $0 | 4 | V.P. of Finance & CFO | 29 Mar 2023, 16:25 |
| PBLA | Panbela Therapeutics, Inc. | 30 Jan 2023 | 2 | $0 | 4 | V.P. of Finance & CFO | 01 Feb 2023, 15:36 |
| PBLA | Panbela Therapeutics, Inc. | 13 Sep 2021 | 1 | $0 | 4 | V.P. of Finance & CFO | 15 Sep 2021, 17:59 |